Blood Processing Devices and Consumables Market Size, Share and Growth Outlook, 2026

Blood Processing Devices and Consumables Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Blood Processing Devices and Consumables Market size is forecast to increase from $57.99 Billion in 2026 to $101.89 Billion in 2034 at a CAGR of 7.3% between 2026 and 2034.

The Blood Processing Devices and Consumables market report provides detailed analysis and outlook of Blood Processing Devices and Consumables segments including By Product Type (Blood Processing Devices, Blood Processing Consumables ), By Technology (Centrifugation, Membrane Filtration, Automated Robotic Processing, AI-Enabled Cross-Matching), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Blood Banks & Transfusion Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Blood Processing Devices and Consumables Industry Overview

Automation and Specialized Collection Technologies Driving Industry Advancement

The blood processing devices and consumables industry plays a critical role in modern healthcare, supporting blood collection, processing, separation, storage, testing, and transfusion workflows across hospitals, blood banks, diagnostic laboratories, and biopharmaceutical facilities. Growing demand for high-quality blood components, increasing laboratory testing volumes, and rising adoption of advanced cellular therapies are driving continuous innovation in processing technologies and consumable products. Healthcare organizations are increasingly investing in automated systems, specialized collection devices, and enhanced logistics infrastructure to improve efficiency, reduce operational errors, and maintain sample integrity throughout the blood processing lifecycle. These developments are strengthening the industry's ability to support evolving clinical and research requirements.

Specialized Blood Collection Devices Enhancing Sample Quality

A major trend within the blood processing devices and consumables industry is the development of specialized collection tools designed to optimize workflow efficiency and patient experience. In April 2026, manufacturers introduced devices specifically engineered for small-volume blood collection applications. These solutions are designed to reduce patient discomfort during sample acquisition while preserving the integrity of collected specimens for sensitive processing procedures. The growing demand for precision diagnostics and specialized laboratory testing is increasing the need for collection devices capable of maintaining sample quality even when working with limited blood volumes. Such innovations are particularly valuable in pediatric testing, chronic disease monitoring, and advanced diagnostic applications.

Automated Cell Processing Systems Improving Laboratory Productivity

Healthcare providers and diagnostic laboratories continue to expand the deployment of automated cell processor devices to enhance operational performance and testing consistency. These systems reduce manual handling requirements, increase processing throughput, and support standardized outcomes across critical laboratory procedures. Automated platforms are increasingly utilized for blood grouping, phenotyping, and qualitative screening tests, helping laboratories improve efficiency while minimizing variability associated with manual workflows. The growing emphasis on automation reflects broader industry efforts to improve quality control, reduce labor-intensive processes, and meet increasing demand for rapid and reliable blood processing services.

Advanced Cold Chain Logistics Supporting Sensitive Biological Materials

The increasing complexity of biological samples is driving demand for highly specialized storage and transportation solutions within the blood processing industry. There is a growing focus on logistics services capable of maintaining ultra-low temperature conditions reaching as low as -85°C. These capabilities are essential for preserving plasma and other temperature-sensitive blood components used in pharmaceutical manufacturing, clinical diagnostics, and advanced therapeutic applications. Reliable ultra-low temperature logistics infrastructure helps maintain product stability, prevent degradation, and ensure compliance with stringent regulatory requirements. As biologic therapies and specialized blood-derived products become more prevalent, advanced cold chain solutions are becoming a critical component of blood processing operations worldwide.

Blood Processing Devices and Consumables Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Blood Processing Devices and Consumables market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Haemonetics Corporation, Terumo BCT, Inc. , Fresenius Kabi AG, Grifols, S.A., Abbott Laboratories, Danaher Corporation , Becton, Dickinson and Company , Thermo Fisher Scientific Inc., Immucor, Inc., Maco Pharma International GmbH. The Blood Processing Devices and Consumables market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Blood Processing Devices and Consumables industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Blood Processing Devices and Consumables Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Blood Processing Devices and Consumables companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Blood Processing Devices and Consumables markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Blood Processing Devices and Consumables Market Competitive Benchmarking and Company Analysis

Leading companies in Blood Processing Devices and Consumables industry include- Haemonetics Corporation, Terumo BCT, Inc. , Fresenius Kabi AG, Grifols, S.A., Abbott Laboratories, Danaher Corporation , Becton, Dickinson and Company , Thermo Fisher Scientific Inc., Immucor, Inc., Maco Pharma International GmbH. The Blood Processing Devices and Consumables market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Blood Processing Devices and Consumables Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Blood Processing Devices and Consumables market remains one of the strongest-performing segments in the country.
The US Blood Processing Devices and Consumables Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Blood Processing Devices and Consumables market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Blood Processing Devices and Consumables industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Blood Processing Devices and Consumables markets

Canada's strong Blood Processing Devices and Consumables sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Blood Processing Devices and Consumables market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Blood Processing Devices and Consumables Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Blood Processing Devices and Consumables market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Blood Processing Devices and Consumables population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Blood Processing Devices and Consumables industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Blood Processing Devices and Consumables market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Blood Processing Devices and Consumables sales through 2034

France Blood Processing Devices and Consumables companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Blood Processing Devices and Consumables Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Blood Processing Devices and Consumables distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Blood Processing Devices and Consumables Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Blood Processing Devices and Consumables market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Blood Processing Devices and Consumables industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Blood Processing Devices and Consumables industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Blood Processing Devices and Consumables Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Blood Processing Devices and Consumables market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Blood Processing Devices and Consumables market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Blood Processing Devices and Consumables Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Blood Processing Devices and Consumables Market Segmentation

By Product Type
Blood Processing Devices
Blood Processing Consumables
By Technology
Centrifugation
Membrane Filtration
Automated Robotic Processing
AI-Enabled Cross-Matching
By End-User
Hospitals and Clinics
Diagnostic Laboratories
Blood Banks & Transfusion Centers

Top Companies in Blood Processing Devices and Consumables Industry

Haemonetics Corporation
Terumo BCT, Inc.
Fresenius Kabi AG
Grifols, S.A.
Abbott Laboratories
Danaher Corporation
Becton, Dickinson and Company
Thermo Fisher Scientific Inc.
Immucor, Inc.
Maco Pharma International GmbH

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025